François Radvanyi

Person

Paris, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Bladder cancer biomarker proteins
- Patent number 11,536,724
- Issue date Dec 27, 2022
- Polyquant GmbH
- Jerome Garin
- G01 - MEASURING TESTING
Information Patent Grant
Prediction of recurrence for bladder cancer by a protein signature...
- Patent number 10,809,261
- Issue date Oct 20, 2020
- Deutsches Krebsforschungszentrum
- Christoph Schröder
- G01 - MEASURING TESTING
Information Patent Grant
Prediction of recurrence for bladder cancer by a protein signature...
- Patent number 9,678,075
- Issue date Jun 13, 2017
- Deutsches Krebsforschungszentrum
- Christoph Schröder
- G01 - MEASURING TESTING
Information Patent Grant
Tyrosine kinase receptor TYRO3 as a therapeutic target in the treat...
- Patent number 9,233,144
- Issue date Jan 12, 2016
- Institut Curie
- Isabelle Bernard-Pierrot
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Means for detecting and treating pathologies linked to FGFR3
- Patent number 7,135,311
- Issue date Nov 14, 2006
- Institut Curie
- Cappellen David
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
PREDICTION OF RECURRENCE FOR BLADDER CANCER BY A PROTEIN SIGNATURE...
- Publication number 20210123914
- Publication date Apr 29, 2021
- DEUTSCHES KREBSFORSCHUNGSZENTRUM
- Christoph SCHRODER
- G01 - MEASURING TESTING
Information Patent Application
BLADDER CANCER BIOMARKER PROTEINS
- Publication number 20180372754
- Publication date Dec 27, 2018
- Polyquant GmbH
- Jerome GARIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TYRO3 ANTIBODIES AND USES THEREOF
- Publication number 20180105596
- Publication date Apr 19, 2018
- ELSALYS BIOTECH
- VANESSA DUONG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREDICTION OF RECURRENCE FOR BLADDER CANCER BY A PROTEIN SIGNATURE...
- Publication number 20170336414
- Publication date Nov 23, 2017
- DEUTSCHES KREBSFORSCHUNGSZENTRUM
- Christoph SCHRODER
- G01 - MEASURING TESTING
Information Patent Application
PREDICTION OF RECURRENCE FOR BLADDER CANCER BY A PROTEIN SIGNATURE...
- Publication number 20140193927
- Publication date Jul 10, 2014
- INSTITUT CURIE
- Christoph Schröder
- G01 - MEASURING TESTING
Information Patent Application
CDKN2A AS A PROGNOSTIC MARKER IN BLADDER CANCER
- Publication number 20130059303
- Publication date Mar 7, 2013
- FRANCOIS RADVANYI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR PREDICTING THE SENSITIVITY OF A TUMOR TO AN EPIGENETIC T...
- Publication number 20120282167
- Publication date Nov 8, 2012
- INSTITUT CURIE
- Céline Vallot
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TYROSINE KINASE RECEPTOR TYRO3 AS A THERAPEUTIC TARGET IN THE TREAT...
- Publication number 20120034167
- Publication date Feb 9, 2012
- INSTITUT CURIE
- Isabelle Bernard-Pierrot
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
P38Alpha as a Therapeutic Target in Bladder Carcinoma
- Publication number 20100166737
- Publication date Jul 1, 2010
- INSTITUT CURIE
- Isabelle Bernard-Pierrot
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

François Radvanyi

Person

Patents Grantslast 30 patents

Bladder cancer biomarker proteins

Prediction of recurrence for bladder cancer by a protein signature...

Prediction of recurrence for bladder cancer by a protein signature...

Tyrosine kinase receptor TYRO3 as a therapeutic target in the treat...

Means for detecting and treating pathologies linked to FGFR3

Patents Applicationslast 30 patents

PREDICTION OF RECURRENCE FOR BLADDER CANCER BY A PROTEIN SIGNATURE...

BLADDER CANCER BIOMARKER PROTEINS

ANTI-TYRO3 ANTIBODIES AND USES THEREOF

PREDICTION OF RECURRENCE FOR BLADDER CANCER BY A PROTEIN SIGNATURE...

PREDICTION OF RECURRENCE FOR BLADDER CANCER BY A PROTEIN SIGNATURE...

CDKN2A AS A PROGNOSTIC MARKER IN BLADDER CANCER

METHOD FOR PREDICTING THE SENSITIVITY OF A TUMOR TO AN EPIGENETIC T...

TYROSINE KINASE RECEPTOR TYRO3 AS A THERAPEUTIC TARGET IN THE TREAT...

P38Alpha as a Therapeutic Target in Bladder Carcinoma